255 related articles for article (PubMed ID: 9396979)
1. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
Bernstein DI; Schoenwetter WF; Nathan RA; Storms W; Ahlbrandt R; Mason J
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
LaForce CF; Corren J; Wheeler WJ; Berger WE;
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
[TBL] [Abstract][Full Text] [Related]
4. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
Meltzer EO; Casale TB; Nathan RA; Thompson AK
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423
[TBL] [Abstract][Full Text] [Related]
5. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
Clin Ther; 2006 Oct; 28(10):1658-69. PubMed ID: 17157121
[TBL] [Abstract][Full Text] [Related]
6. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
Nelson HS; Reynolds R; Mason J
Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
Lockey RF; Widlitz MD; Mitchell DQ; Lumry W; Dockhorn R; Woehler T; Grossman J
Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719
[TBL] [Abstract][Full Text] [Related]
8. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit.
Day JH; Briscoe MP; Welsh A; Smith JN; Clark A; Ellis AK; Mason J
Ann Allergy Asthma Immunol; 1997 Dec; 79(6):533-40. PubMed ID: 9433370
[TBL] [Abstract][Full Text] [Related]
9. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
Berkowitz RB; Woodworth GG; Lutz C; Weiler K; Weiler J; Moss M; Meeves S
Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
[TBL] [Abstract][Full Text] [Related]
10. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.
Hampel F; Ratner P; Mansfield L; Meeves S; Liao Y; Georges G
Ann Allergy Asthma Immunol; 2003 Oct; 91(4):354-61. PubMed ID: 14582814
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies.
Bronsky EA; Falliers CJ; Kaiser HB; Ahlbrandt R; Mason JM
Allergy Asthma Proc; 1998; 19(3):135-41. PubMed ID: 9642436
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.
Prenner BM; Capano D; Harris AG
Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
[TBL] [Abstract][Full Text] [Related]
15. Safety of fexofenadine in children treated for seasonal allergic rhinitis.
Graft DF; Bernstein DI; Goldsobel A; Meltzer EO; Portnoy J; Long J
Ann Allergy Asthma Immunol; 2001 Jul; 87(1):22-6. PubMed ID: 11476456
[TBL] [Abstract][Full Text] [Related]
16. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
17. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.
Wahn U; Meltzer EO; Finn AF; Kowalski ML; Decosta P; Hedlin G; Scheinmann P; Bachert C; Rosado Pinto JE; Baena-Cagnani C; Potter P; Simons FE; Ruuth E
J Allergy Clin Immunol; 2003 Apr; 111(4):763-9. PubMed ID: 12704355
[TBL] [Abstract][Full Text] [Related]
18. Intranasal phototherapy is more effective than fexofenadine hydrochloride in the treatment of seasonal allergic rhinitis: results of a pilot study.
Garaczi E; Boros-Gyevi M; Bella Z; Csoma Z; Kemény L; Koreck A
Photochem Photobiol; 2011; 87(2):474-7. PubMed ID: 21366599
[TBL] [Abstract][Full Text] [Related]
19. Fexofenadine: new preparation. Terfenadine, without cardiotoxicity.
Prescrire Int; 1999 Feb; 8(39):11-3. PubMed ID: 10557567
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.
Casale TB; Andrade C; Qu R
Allergy Asthma Proc; 1999; 20(3):193-8. PubMed ID: 10389553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
